XML 28 R10.htm IDEA: XBRL DOCUMENT v2.3.0.15
Significant Accounting Policies and Basis of Consolidation
9 Months Ended
Sep. 30, 2011
Significant Accounting Policies and Basis of Consolidation 
Significant Accounting Policies and Basis of Consolidation

 

 

Note C. Significant Accounting Policies and Basis of Consolidation

 

There have been no material changes from the Significant Accounting Policies and Basis of Presentation previously disclosed in Part II, Item 8, contained within “Notes to Consolidated Financial Statements” of the Company’s Annual Report on Form 10-K for the fiscal year ending December 31, 2010.

 

Use of Estimates

 

The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period reported. Management believes the most significant estimates include the net realizable value of accounts receivable and inventory, warranty provisions, the recoverability of long-lived assets, the recoverability of deferred tax assets and the fair value of equity, financial instruments and revenue. Actual results could differ from these estimates.

 

Reclassifications

 

Certain prior-year balances have been reclassified to conform to current-year presentations.

 

Basis of Consolidation

 

The consolidated financial statements include the accounts of Satcon Technology Corporation and its wholly owned subsidiaries (Satcon Power Systems Canada, Ltd. and Satcon Trading (Shenzhen) Co., Ltd.) and its discontinued operating subsidiaries (Satcon Applied Technology, Inc., Satcon Electronics, Inc. and Satcon Power Systems, Inc.). All intercompany accounts and transactions have been eliminated in consolidation.

 

Revenue Recognition

 

The Company recognizes revenue from product sales when there is persuasive evidence of an arrangement, the fee is fixed or determinable, delivery of the product to the customer has occurred and the Company has determined that collection of the fee is reasonably assured. Title to the product passes upon shipment of the product, as the products are typically shipped FOB shipping point, unless otherwise agreed upon in advance with the customer. If the product requires installation to be performed by the Company, all revenue related to the product is deferred and recognized upon the completion of the installation. If the product requires specific customer acceptance, revenue is deferred until customer acceptance occurs or the acceptance provisions lapse, unless the Company can objectively and reliably demonstrate that the criteria specified in the acceptance provisions are satisfied. When appropriate the Company provides for a warranty reserve at the time the product revenue is recognized.  If a contract involves the provision of multiple elements and the elements qualify for separation, total estimated contract revenue is allocated to each element based on the relative fair value of each element provided.  The amount of revenue allocated to each element is limited to the amount that is not contingent upon the delivery of another element in the future.  Revenue is recognized on each element as described above.

 

Contract Losses

 

When the current estimates of total contract revenue for a customer order indicates a loss, a provision for the entire loss on the contract is recorded. For the nine months ended September 30, 2011, the Company recorded a contract loss on a customer order of approximately $5.1 million.  At September 30, 2011, the accrued contract loss was approximately $0.3 million.  The excess costs over projected revenues are recorded as a component of both cost of sales and research and development expense.

 

Cost of product revenue includes materials, labor, overhead, warranty and freight.

 

Deferred revenue primarily consists of cash received for extended product warranties, preventative maintenance plans and up-time guarantee programs.  Deferred revenue also consists of payments received from customers in advance of services performed, product shipped or installation completed.  When an item is deferred for revenue recognition purposes, the deferred revenue is recorded as a liability and the deferred costs are recorded as a component of inventory in the consolidated balance sheets.

 

Unbilled Contract Costs and Fees

 

Unbilled contract costs and fees represent revenue recognized in excess of amounts billed due to contractual provisions or deferred costs that have not been recognized as revenue or billed to the customer.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include demand deposits and highly-liquid investments with maturities of three months or less when acquired. Cash equivalents are stated at cost, which approximates market value. At September 30, 2011 and December 31, 2010, the Company had no restricted cash.

 

Accounts Receivable

 

Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. The estimated allowance for uncollectible amounts is based primarily on a specific analysis of accounts in the receivable portfolio and historical write-off experience. While management believes the allowance to be adequate, if the financial condition of our customers were to deteriorate, resulting in impairment of their ability to make payments, additional allowances may be required.

 

Inventory

 

Inventory is valued at the lower of actual cost to purchase and/or manufacture the inventory or the current estimated market value of the inventory, and costs are determined based on the first-in, first-out method of accounting and include material, labor and manufacturing overhead costs. A significant decrease in demand for the Company’s products could result in a short-term increase in the cost of inventory purchases and an increase of excess inventory quantities on hand. In addition, the industry is characterized by rapid technological change, frequent new product development, and rapid product obsolescence that could result in an increase in the amount of obsolete inventory quantities on hand. Therefore, although the Company makes every effort to ensure the accuracy of its forecasts of future product demand, any significant unanticipated changes in demand or technological developments could have a significant impact on the value of the inventory and reported operating results.  The Company records, as a charge to cost of product revenue, any amounts required to reduce the carrying value to net realizable value.

 

Warranty

 

The Company offers warranty coverage for our products for period of 5 years after shipment. The Company estimates the anticipated costs of repairing products under warranty based on the historical or expected cost of the repairs and expected failure rates. The assumptions used to estimate warranty accruals are re-evaluated quarterly, at a minimum, in light of actual experience and, when appropriate, the accruals or the accrual percentage is adjusted based on specific estimates of project repair costs and quantity of product returns. The Company’s determination of the appropriate level of warranty accrual is based on estimates of the percentage of units affected and the repair costs. Estimated warranty costs are recorded at the time of sale of the related product, and are recorded within cost of sales in the consolidated statements of operations.  See Note J., Product Warranties.

 

Subordinated Convertible Notes

 

The subordinated convertible notes include features that qualify as embedded derivatives, such as (i) the holder’s right to convert, (ii) the Company’s option to force conversion into shares of common stock of the Company, and (iii) the holder’s prepayment options. The Company has elected to measure the subordinated convertible notes and the embedded derivatives in their entirety at fair value with changes in fair value recognized as a change in fair value of subordinated convertible notes and warrant liabilities in the statement of operations. This election was made by the Company after concluding that several of the derivatives cannot be reliably measured nor reliably associated with another derivative that can be reliably measured and determining that the aggregate fair value of the notes to be more meaningful in the context of the Company’s consolidated financial statements than if separate fair values were assigned to each of the multiple embedded instruments contained in such notes.

 

Foreign Currency Translation

 

As of April 1, 2010, the Company determined that the functional currency of its foreign subsidiary was the US dollar.  As the functional currency changed from the foreign currency to the reporting currency, the translation adjustments as of April 1, 2010 remains as a component of accumulated other comprehensive income (loss).  Prior to this determination, the functional currency was the local currency, assets and liabilities were translated at the rates in effect at the balance sheet dates, while stockholders’ equity (deficit) including the long-term portion of intercompany advances was translated at historical rates. Statements of operations and cash flow amounts were translated at the average rate for the period. Translation adjustments were included as a component of accumulated other comprehensive income (loss). The Company records the impact from foreign currency transactions as a component of other income (expense).  Foreign currency gains and losses were a charge of $1.0 million and a gain of $0.4 million and a charge of $1.2 million and a gain of $24,000 for the three and nine months ended September 30, 2011 and 2010, respectively.  All foreign currency transaction gains and losses were recorded as a component of other income (loss), net.

 

Foreign Currency Hedges

 

The Company uses foreign currency contracts to manage its exposure to changes in foreign currency exchange rates associated with our foreign currency denominated receivables. The Company primarily hedges foreign currency exposure to the Euro. The Company does not engage in trading, market making or speculative activities in the derivatives markets. The foreign currency contracts utilized by the Company do not qualify for hedge accounting treatment, and as a result, any fluctuations in the value of these foreign currency contracts are recognized in other loss (income) in our consolidated statements of operations as incurred. The fluctuations in the value of these foreign currency contracts do, however, largely offset the impact of changes in the value of the underlying risk that they are intended to economically hedge.  In April 2011, the Company entered into a foreign currency hedge with a bank with a notational amount of approximately $1.6 million, which matured on July 18, 2011.

 

At September 30, 2011 and December 31, 2010 there were no foreign currency hedges outstanding.

 

The following table shows the changes in the fair value of our foreign currency contract recorded in net loss during the three and nine month periods ended September 30, 2011:

 

 

 

(Loss) Gain
Three Months Ended

 

(Loss) Gain
Nine Months Ended

 

 

 

September 30, 2011

 

September 30, 2011

 

Foreign currency hedges (a)

 

$

10,308

 

$

 

 

 

(a)          The Company recorded transaction gain (losses) associated with the re-measurement of its foreign denominated assets of ($3.306) and $108,730 in the three and nine months ended September 30, 2011, respectively. Transaction losses were included in Other (loss) income in the consolidated statements of operations. The net impact of transaction (losses) gains associated with the re-measurement of the foreign denominated assets and the losses incurred on the foreign currency hedges was a net gain of $7,002 and a net loss of $108,730 for the three and nine month period ended September 30, 2011, respectively.

 

Income Taxes

 

The Company accounts for income taxes utilizing the asset and liability method for accounting and reporting for income taxes. Under this method, deferred tax assets and deferred tax liabilities are recognized based on temporary differences between the financial reporting and income tax basis of assets and liabilities using statutory rates. In addition, the Company is required to establish a valuation allowance against net deferred tax assets if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

 

The Company is allowed to recognize the tax benefits of uncertain tax positions only where the position is “more likely than not” to be sustained assuming examination by tax authorities.  The amount recognized is the amount that represents the largest amount of tax benefit that is greater than 50% likely of being ultimately realized.  A liability is recognized for any benefit claimed, or expected to be claimed, in a tax return in excess of the benefit recorded in the financial statements, along with any interest and penalties (if applicable) on that excess.  In addition, the Company is required to provide a tabular reconciliation of the change in the aggregate unrecognized tax benefits claimed, or expected to be claimed, in tax returns and disclosure relating to the accrued interest and penalties for unrecognized tax benefits.  Discussion is also required for those uncertain tax positions where it is reasonably possible that the estimate of the tax benefit will change significantly in the next twelve months.

 

As of December 31, 2010, the Company had federal and state net operating loss (“NOL”) carry forwards and federal and state R&D credit carry forwards, which may be available to offset future federal and state income tax liabilities which expire at various dates through 2031. Utilization of the NOL and R&D credit carry forwards may be subject to a substantial annual limitation due to ownership change limitations that have occurred previously or that could occur in the future provided by Sections 382 or 383 of the Internal Revenue Code of 1986, as well as similar state and foreign provisions. These ownership changes may limit the amount of NOL and R&D credit carry forwards that can be utilized annually to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50 percentage points over a rolling three-year period. Since the Company’s formation, the Company has raised capital through the issuance of capital stock on several occasions (both pre and post initial public offering) which, combined with the purchasing shareholders’ subsequent disposition of those shares, may have resulted in a change of control, as defined by Section 382, or could result in a change of control in the future upon subsequent disposition.

 

The Company commissioned a study to determine whether Sections 382 or 383 could limit the use of our carryforwards in this manner. After completing this study in 2010, the Company has concluded that the limitation will not have a material impact on its ability to utilize its net operating loss or credit carryforwards.  In January 2011, the Company’s board of directors adopted a shareholder rights agreement designed to protect the Company’s ability to use the NOLs for income tax purposes. However, the adoption of the shareholder rights agreement cannot guarantee complete protection against an “ownership change” and it remains possible that one may occur.  See Note R. Shareholders Rights Agreement.

 

The tax years 1996 through 2010 remain open to examination by major taxing jurisdictions to which the Company is subject, which are primarily in the United States, as carryforward attributes generated in years past may still be adjusted upon examination by the Internal Revenue Service or state tax authorities if they are or will be used in a future period.  The Company is currently not under examination by the Internal Revenue Service or any other jurisdiction for any tax years.  The Company did not recognize any interest and penalties associated with unrecognized tax benefits in the accompanying financial statements.  The Company would record any such interest and penalties as a component of interest expense.  The Company does not expect any material changes to the unrecognized benefits within 12 months of the reporting date.

 

The Company currently has a provision for income taxes related to state of California and its operations in China.

 

Accounting for Stock-based Compensation

 

The Company has several stock-based compensation plans, as well as stock options issued outside of such plans as an inducement to engage new executives.  Stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the service period.

 

The Company uses the Black-Scholes valuation model for valuing options.  This model incorporates several assumptions, including volatility, expected life and discount rate.  The Company uses historical volatility as it believes it is more reflective of market conditions and a better indicator of volatility. The Company uses historical information in the calculation of expected life for its “plain-vanilla” option grants.  If the Company determines that another method used to estimate expected volatility is more reasonable than the Company’s current methods, or if another method for calculating these input assumptions is prescribed by authoritative guidance, the fair value calculated for share-based awards could change significantly. Higher volatility and longer expected lives would result in an increase to share-based compensation determined at the date of grant.

 

The Company recognized the full impact of its stock-based compensation plans in the consolidated financial statements for the three and nine months ended September 30, 2011 and 2010 and did not capitalize any such costs on the consolidated balance sheets, as such costs that qualified for capitalization were not material.  The following table presents stock-based compensation expense, including amounts related to employees’ participation in the Employee Stock Purchase Plan (“ESPP”) of approximately $0.2 million and $0.7 million for the three and nine months ended September 30, 2011, respectively (See Note Q. Employee Benefit Plan), included in the Company’s consolidated statement of operations:

 

 

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

Cost of product revenue

 

$

119,314

 

$

55,016

 

$

347,194

 

$

167,642

 

Research and development

 

316,265

 

137,621

 

900,625

 

360,037

 

Selling, general and administrative expenses

 

1,165,100

 

711,662

 

3,405,107

 

2,178,996

 

Stock based compensation expense from continuing operations before tax

 

1,600,679

 

904,299

 

4,652,926

 

2,706,675

 

Stock based compensation expense from discontinued operations

 

 

 

 

(18,357

)

Total stock based compensation expense before tax

 

1,600,679

 

904,299

 

4,652,926

 

1,784,019

 

Income tax benefit

 

 

 

 

(18,357

)

Net stock-based compensation expense

 

$

1,600,679

 

$

904,299

 

$

4,652,926

 

$

2,688,318

 

 

Compensation expense associated with the granting of stock options to employees is being recognized on a straight-line basis over the service period of the option.  In instances where the actual compensation expense would be greater than that calculated using the straight-line method, the actual compensation expense is recorded in that period.

 

The weighted average grant date fair value of options granted during the three and nine months ended September 30, 2011 and 2010 was $1.57 and $3.32, and $3.04 and $2.42, respectively, per option.  The fair value of each stock option is estimated on the date of the grant using the Black-Scholes option-pricing model with the following range of assumptions:

 

 

 

Three Months Ended

 

Nine Months Ended

Assumptions:

 

September 30, 2011

 

September 30, 2010

 

September 30, 2011

 

September 30, 2010

Expected life

 

5.6 years (1)

 

5.6 years (1)

 

0 to 5.6 years (1)

 

5.0 to 6.25 years (1)

Expected volatility ranging from

 

75.26% to 77.18% (2)

 

72.8% to 73.93% (2)

 

73.59% to 77.18% (2)

 

72.4% to 76.5% (2)

Dividends

 

none

 

none

 

none

 

none

Risk-free interest rate

 

1% (3)

 

1.50% (3)

 

1% to 2.15%  (3)

 

1.10% to 2.50% (3)

Forfeiture Rate (4)

 

6.25%

 

6.25%

 

0% to 6.25%

 

0% to 6.25%

 

(1)          The option life for the three and nine months ended September 30, 2011 and 2010 was determined using actual option experience.

(2)          The stock volatility for each grant is measured using the weighted average of historical daily price changes of the Company’s common stock over the most recent period equal to the expected option life of the grant, the historical short term trend of the option and other factors, such as expected changes in volatility arising from planned changes in the Company’s business operations.

(3)          The risk-free interest rate for each grant is equal to the U.S. Treasury yield curve in effect at the time of grant for instruments with a similar expected life.

(4)          The estimated forfeiture rate for each option grant is between 0% - 6.25%.  The Company periodically reviews the estimated forfeiture rate, in light of actual experience.

 

At September 30, 2011 approximately $11.1 million in unrecognized compensation expense remains to be recognized over a weighted average period of 2.4 years.  The table below summarizes compensation expense expected to be recognized associated with employee stock options over the next five years as follows:

 

Calendar Years Ending December 31,

 

Non Cash
Stock-Based
Compensation
Expense

 

2011

 

$

1,364,478

 

2012

 

4,082,098

 

2013

 

3,038,325

 

2014

 

2,200,591

 

2015

 

411,096

 

Total

 

$

11,096,588

 

 

Concentration of Credit Risk

 

Financial instruments that subject the Company to concentrations of credit risk principally consist of cash equivalents, trade accounts receivable, unbilled contract costs and deposits in bank accounts.  The Company deposits its cash and invests in short-term investments primarily through a national commercial bank. Deposits in excess of amounts insured by the Federal Deposit Insurance Corporation (FDIC) are exposed to loss in the event of nonperformance by the institution.

 

The Company’s trade accounts receivable and unbilled contract costs and fees are primarily from sales to commercial customers. The Company does not require collateral and has not historically experienced significant credit losses related to receivables, letters of credit or unbilled contract costs and fees from individual customers or groups of customers in any particular industry or geographic area.

 

Significant customers are defined as those customers that account for 10% or more of total net revenue in a fiscal year or 10% or more of accounts receivable at the end of a fiscal period.  The table below details out customers that were considered significant as it pertains to both revenues for the three and nine month periods ended September 30, 2011 and 2010 and accounts receivable at September 30, 2011 and December 31, 2010.

 

 

 

 

Revenue

 

Accounts Receivable

Period

 

Three Months ended September 30,

 

Nine Months ended September 30,

 

At September 30, 2011 and December 31, 2010

2011

 

SunPower Corporation (approximately 11.4%)

 

SunPower Corporation (approximately 12.0%)

 

GCL Solar Limited (approximately 16.2%)
SunEdison Corporation (approximately 11.8%)

2010

 

CE Solar (approximately 16.8%) Amun-Re a.s. (approximately 15.0%) SunEdison (approximately 11.9%)

 

CE Solar (approximately 14.8%) Amun-Re a.s. (approximately 14.1%)

 

CE Solar (approximately 12.8%)
GCL Solar Limited (approximately 11.4%) ** Enel Green Power (approximately 10.6%) **

 

 

** The accounts receivable associated with these customers were backed by irrevocable letters of credit at December 31, 2010.

 

Research and Development Costs

 

The Company expenses research and development costs as incurred. Cost of research and development includes costs incurred in connection with both funded research and development and unfunded research and development activities.

 

Comprehensive Income (Loss)

 

Comprehensive income (loss) includes net loss and foreign currency translation adjustments prior to the changing of the functional currency of the Company’s Canadian subsidiary to the US dollar.

 

Fair Value of Financial Instruments

 

The Company’s financial instruments consist of cash equivalents, accounts receivable, unbilled contract costs and fees, warrants to purchase shares of common stock, accounts payable, subordinated notes payable, subordinated convertible notes and the line of credit. The estimated fair values have been determined through information obtained from market sources and management estimates.  The Company’s warrant liability and subordinated convertible notes are recorded at fair value.  See “Fair Value Measurements” below.  The carrying value of the subordinated notes payable, as of September 30, 2011, is not materially different from the fair value of the notes. The estimated fair values of the remaining financial instruments approximate their carrying values at September 30, 2011 and December 31, 2010.

 

Fair Value Measurements

 

The Company’s financial assets and liabilities are measured using inputs from the three levels of fair value hierarchy which are as follows:

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

Assets and liabilities measured at fair value on a recurring basis as of September 30, 2011 are as follows:

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

 

 

in Active

 

Significant

 

 

 

 

 

 

 

Markets for

 

Other

 

Significant

 

 

 

Balance as of

 

Identical

 

Observable

 

Unobservable

 

 

 

September 30,

 

Assets

 

Inputs

 

Inputs

 

Description

 

2011

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

Money market funds

 

$

 

$

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$

 

$

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

Warrant liabilities (1)

 

$

272,106

 

$

 

$

272,106

 

$

 

Subordinated Convertible Notes (2)

 

$

15,250,000

 

$

 

$

 

$

15,250,000

 

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

$

15,522,106

 

$

 

$

272,106

 

$

15,250,000

 

 

Assets and liabilities measured at fair value on a recurring basis as of December 31, 2010 are as follows:

 

 

 

Fair Value Measurements at Reporting Date Using

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

 

 

in Active

 

Significant

 

 

 

 

 

 

 

Markets for

 

Other

 

Significant

 

 

 

Balance as of

 

Identical

 

Observable

 

Unobservable

 

 

 

December 31,

 

Assets

 

Inputs

 

Inputs

 

Description

 

2010

 

(Level 1)

 

(Level 2)

 

(Level 3)

 

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

Money market funds

 

$

 

$

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$

 

$

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

Warrant liabilities (1)

 

$

5,454,109

 

$

 

$

5,454,109

 

$

 

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

$

5,454,109

 

$

 

$

5,454,109

 

$

 

 

 

(1)          The Company’s Level 2 financial liabilities consist of long term investor warrant liabilities comprised of the Warrant As, Warrant Cs, the warrants issued to the investors in connection with the 2007 preferred stock financing (the “2007 Financing Warrants”) and the placement agent warrants.  The fair value of the Warrant As and Warrant Cs is being estimated using a binomial lattice model and the fair value of the placement agent warrants and the 2007 Financing Warrants is being estimated using the Black-Scholes option pricing model. (see Note K. Warrant Liabilities-Valuation — Methodology and Significant Assumptions; Note L - Redeemable Convertible Series B and Series C Preferred Stock; and “Warrant Liabilities” below).

(2)          The Company’s Level 3 financial liabilities consist of a subordinated convertible notes.  (See Note I.)  The valuation of this instrument utilizes a continuous-variable stochastic process in the form of a Monte-Carlo Simulation and includes unobservable inputs supported by little or no market activity such as discount rate applicable to the instrument’s debt-like feature, probabilities of debt-like and equity-like positions, and various probabilities of occurrences of certain future events. The analysis also includes the contractual terms of instrument in the form of interest rate, timing and extent of principal and interest payments, and time to maturity.

 

Warrant Liabilities

 

Upon issuance in 2006, the Warrant As, Warrant Bs and Warrant Cs, along with the Placement Agent Warrants (together the “Warrants”), did not meet the requirements for equity classification, because such warrants (a) must be settled in registered shares, (b) are subject to substantial liquidated damages if the Company is unable to maintain the effectiveness of the resale registration of the shares and (c) provide a cash-out election using a Black-Scholes valuation under various circumstances.  Therefore these Warrants are required to be accounted for as freestanding derivative instruments.  Changes in fair value are recognized in the statement of operations under the caption “Change in fair value of warrant liabilities.”

 

The Company determined the fair value of the Warrant As and Warrant Cs and placement agent warrants using valuation models it considers to be appropriate. The Company’s stock price has the most significant influence on the fair value of its warrants. An increase in the Company’s common stock price would cause the fair values of the warrants to increase, because the exercise price of the warrants is fixed at $1.815 per share, and result in a charge to our statement of operations. A decrease in the Company’s stock price would likewise cause the fair value of the warrants to decrease and result in a credit to our statement of operations. See Note K. Warrant Liabilities for valuation discussion.

 

Redeemable Convertible Series B Preferred Stock

 

The Company initially accounted for its issuance of Series B Preferred Stock and associated warrants by allocating the proceeds received net of transaction costs based on the relative fair value of the Series B Preferred Stock and the warrants issued to the investors, and then to any beneficial conversion rights contained in the convertible redeemable preferred securities.  The Company determined the initial value of the Series B Preferred Stock and investor warrants using valuation models it considers to be appropriate.  The Series B Preferred Stock was classified within the liability section of the Company’s balance sheet.

 

In October 2010, the holders of the remaining 75 shares of Series B Preferred Stock converted their shares into common stock, resulting in the issuance of 251,677 shares of common stock.

 

Redeemable Convertible Series C Preferred Stock

 

The Company initially accounted for its issuance of Series C Preferred Stock and associated warrants by allocating the proceeds received net of transaction costs based on the relative fair value of the Series C Preferred Stock and the warrants issued to the investors, and then to any beneficial conversion rights contained in the convertible redeemable preferred securities. The Series C Preferred Stock was classified as temporary equity on the balance sheet.  The Company determined the initial value of the Series C Preferred Stock and investor warrants using valuation models it considers to be appropriate.  The Company used the effective interest method to accrete the carrying value of the Series C Preferred Stock through the earliest possible redemption date (November 8, 2011), at which time the value of the Series C Preferred Stock would have been $30.0 million or 120% of its face value and dividends.

 

On October 27, 2010, the holders of all of the outstanding shares of Series C Preferred Stock converted their shares and accumulated dividends into common stock, resulting in the issuance of 27,526,344 shares of common stock.  To induce the Series C Preferred Stock holders to convert their shares, the Company paid these holders an aggregate $1.25 million in cash upon conversion.  The entitlement to a redemption of the Series C Preferred Shares was eliminated upon the holders’ conversion of the Series C Preferred Stock into common shares in October 2010.